Navigation Links
Laser Burn Injuries in One Eye Can Disrupt Protective Immune Privilege in Both Eyes, Study Finds
Date:2/26/2009

defense.

They found that immune privilege was disrupted in both eyes after six hours and continued to be disrupted even after 56 days.

When they injected the same antigen into the eyes of a group of control mice without burns, they observed no inflammation.

Since created in the 1960s, lasers have found their way onto the battlefield, into the operating rooms and into modern research laboratories. While ophthalmologists have been aware of the local damage done by laser burns to retinas, they have not been tuned into the possibility of long-term loss of immune privilege in one or both eyes.

Understanding mechanisms that destroy or disrupt immune privilege will ultimately lead to novel therapies to restore that special privilege not only in the eye but in the brain and the reproductive system as well, she adds.

The next steps for the team will be to study the novel mechanisms that allow for communication between the injured and non-injured eye.

Other scientists involved in the study include: First author, Hong Qiao, MD, PhD, and second author Kenyatta Lucas, PhD, both scientists at Schepens.

Schepens Eye Research Institute is an affiliate of Harvard Medical School and the largest independent eye research institute in the nation.


'/>"/>
SOURCE Schepens Eye Research Institute
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Imaging Diagnostic Systems Updates PMA Filing Status for the New CT Laser Breast Imaging System
2. American Laser Center Offers VelaShape Body Shaping and Cellulite Reduction Treatment
3. UltraShape(R) Non-Invasive Fat Reduction and Body Contouring Clinical Study Results Featured at American Society for Laser Medicine and Surgery Meeting
4. Ekkyo Describes the First Benefits of Controlled Hyperthermia in Humans in "Lasers in Surgery and Medicine"
5. DOT Therapy: Newest Breakthrough Technology in Laser Skin Resurfacing
6. Blue Light Destroys Antibiotic-Resistant Staph Infection - Results Reported in Photomedicine and Laser Surgery Journal
7. Cytopia Concludes Phase I Oral Trial for Vascular-Disrupting Agent, CYT997
8. PharmAthenes Recombinant Butyrylcholinesterase (rBChE) May Play A Neuroprotective Role in Alzheimers Disease
9. Michael J. Fox Foundation Announces $5.6-Million Award for Phase 2 Clinical Trial Studying Neuroprotective Potential of Inosine
10. Preclinical Study Presented at AACR Annual Meeting Shows Peregrines Anti-PS Immunocytokines Can Generate Protective Immune Responses in a Highly Aggressive Breast Cancer Model
11. Anavex presents neuroprotective effects of Anavex 1-41 at the International Conference on Alzheimers Disease 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... BERLIN , April 28, 2015 ... universities of Berlin and the ... Berlin as a central research location ... of scientific, technical and medical information products and services, ... Charité, the Humboldt University (Humboldt-Universität), the Free University ...
(Date:4/28/2015)... , April 28, 2015 ANI Pharmaceuticals, Inc. ... plans to release its first quarter 2015 financial results ... the U.S. financial markets. The earnings press release will ... Company,s website, www.anipharmaceuticals.com . ... and Charlotte C. Arnold , Vice President and ...
(Date:4/28/2015)... , April 28, 2015 /CNW/ - The group representing the ... drug tragedy left a two-hour meeting with Health Canada ... March 6th, Health Canada announced a $180 million support ... than six weeks after the Health Canada announcement and ... fully support the victims, the group representing ...
Breaking Medicine Technology:Elsevier and the Friedrich-Althoff Consortium Collaborate to Create "Archive of Berlin" as a Basis for a Common Research Infrastructure 2Elsevier and the Friedrich-Althoff Consortium Collaborate to Create "Archive of Berlin" as a Basis for a Common Research Infrastructure 3ANI Pharmaceuticals Schedules Conference Call for First Quarter 2015 Financial Results 2Thalidomide Victims Gravely Concerned by Health Canada's Silence 2
... control versus Concerta from 30 minutes to six hours post-dose in ... as 30 minutes post-dose, - Additional analysis suggests Focalin XR provides comparable efficacy ... Concerta ... impact a child,s ability to focus and learn in an educational ...
... ANA773 Acting via ... ... July 7 Anadys Pharmaceuticals,Inc. (Nasdaq: ANDS ) announced today ... for the,treatment of chronic hepatitis C. Based on preclinical pharmacology testing,and ...
Cached Medicine Technology:Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day 2Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day 3Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day 4Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day 5Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day 6Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day 7Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day 8Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 2Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 3Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 4Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 5
(Date:4/28/2015)... NY (PRWEB) April 28, 2015 ... management (IdM/IAM) solutions, announces today that they have ... of the top ten Identity and Access Management ... of the top Identity and Access Management tools ... quarter of 2015 and analyzed their trends to ...
(Date:4/28/2015)... 28, 2015 A new survey from ... lung damage, 66 percent of Americans fear brain damage the ... Awareness Month in May, shed light on the need for ... help prevent a stroke. By controlling modifiable risk factors, ... stroke is a “ brain attack ” that occurs when ...
(Date:4/28/2015)... CA (PRWEB) April 28, 2015 ... the Journal of Molecular Imaging and Biology showed ... a 2nd generation fluorine-18 labeled small-molecule PSMA inhibitor. ... Hopkins University in Baltimore, MD by study co-author, ... initial human evaluation of [18F]DCFPyL demonstrated a number ...
(Date:4/28/2015)... Colorado spine surgeon Donald Corenman, MD, DC has ... education website NECKANDBACK.COM and his back pain ... website has been redesigned to help patients gain a ... of neck and back pain, and conditions and treatments ... answers questions in the neck and back pain forum ...
(Date:4/28/2015)... Everett, WA (PRWEB) April 28, 2015 Dead ... for owners and their property. In many cases, tree removal ... most efficient way to eliminate the threat. , ... various types of tree removal available to property owners today. ... can provide for a job well done. , The article ...
Breaking Medicine News(10 mins):Health News:Tools4ever Chosen as Part of “Top Identity and Access Management Tools - 2015 Edition” 2Health News:National Stroke Association Survey Reveals Americans Fear Brain Damage the Most, but Few Take the Necessary Steps to Prevent a Stroke 2Health News:National Stroke Association Survey Reveals Americans Fear Brain Damage the Most, but Few Take the Necessary Steps to Prevent a Stroke 3Health News:Second Generation 18F-labeled Prostate-Specific Membrane Antigen (PSMA) Targeted Imaging Agent Found to be Highly Sensitive in Detecting Prostate Cancer 2Health News:Second Generation 18F-labeled Prostate-Specific Membrane Antigen (PSMA) Targeted Imaging Agent Found to be Highly Sensitive in Detecting Prostate Cancer 3Health News:Colorado Spine Surgeon Donald Corenman, MD, DC Launches Updated Version of NECKANDBACK.COM and Popular Back Pain Forum ASKSPINEDOC.COM 2Health News:Colorado Spine Surgeon Donald Corenman, MD, DC Launches Updated Version of NECKANDBACK.COM and Popular Back Pain Forum ASKSPINEDOC.COM 3Health News:Tree Removal Methods and Services Discussed in Recent Article by Precision Tree Services 2
... , LONDON, July 13 The market for most ... sales are geared towards the replacement of older systems. Global conglomerates, ... dominate the market. However, there are many small regional vendors that ... in Europe. Innovation will be critical for success in this market. ...
... 13 Uroplasty, Inc. (NYSE Amex: UPI ... markets innovative proprietary products for the treatment of voiding ... No. 7,536,226 entitled, "Electro-Nerve Stimulator System and Methods." The ... methods for treatment of the overactive bladder ("OAB") symptoms ...
... , BEVERLY HILLS, Calif., July 13 Michael Jackson,s ... across America via top TV networks, thanks to PR Whiz Belinda ... joined forces via world media outlets strategized by PR Whiz, Foster, ... drug addict, but rather a chronic insomniac. , ...
... ... , ... 13, 2009 -- Upsher-Smith announces updates to its Website, www.prenexa.com . PreNexa® is the ... prenatal vitamins taken once a day.(1-4) , ,The updated content and offerings on prenexa.com ...
... ... ... 2009 -- Omnetics Connector Corporation , the leading manufacturer of nano-miniature ruggedized connectors, ... miniature electrical connectors. Their proprietary process of terminating signals and grounds on separate ...
... ... and Technology at Online Radiology Medical Group, Inc. (ONRAD), is excited to announce the launch ... ... and Technology at Online Radiology Medical Group, Inc. (ONRAD), is excited to announce the launch ...
Cached Medicine News:Health News:Medical Imaging Modality Vendors Should Focus on Innovation and Alliances with Market Leaders, Advises Frost & Sullivan 2Health News:Medical Imaging Modality Vendors Should Focus on Innovation and Alliances with Market Leaders, Advises Frost & Sullivan 3Health News:Uroplasty Announces Patent Issuance Related to the Urgent(R) PC System 2Health News:Uroplasty Announces Patent Issuance Related to the Urgent(R) PC System 3Health News:PR Whiz Belinda Foster Launches Michael Jackson's Nurse, Cherilyn Lee, on World Media Campaign 2Health News:Upsher-Smith Laboratories, Inc. Updates Prenexa.com with Folic Acid Content, Money-Saving Coupon, and Personalized Address Labels 2Health News:Omnetics' Multi-Contact Nano Connectors Obtain Digital Transmission Rates Over 2 Gb/sec. 2
... PRODUCT SPECIFICATIONS Form: Granular, free-flowing powder EEO (-m r ... (3%): less than or equal to 35C Remelt Point ... (3%): greater than or equal to 300 gm/cm 2 ... less than or equal to 0.10% DNase: Passes test ...
... Form: Granular, free-flowing powder EEO(-m r ): less ... less than or equal to 35.5C Remelt Point (3%): ... (1.5%): greater than or equal to 600 gm/cm ... or equal to 1500 gm/cm 2 Moisture: ...
... traces: chloride (Cl) ≤ 500 mg/kg sulfate (SO 4 ... mg/kg Cd ≤ 5 mg/kg Co ≤ 5 mg/kg ... ≤ 10 mg/kg K ≤ 50 mg/kg Mg ≤ ... mg/kg Ni ≤ 5 mg/kg Pb ≤ 5 mg/kg ...
... Anion traces: chloride (Cl) ≤ 3000 mg/kg sulfate (SO ... 500 mg/kg Cd ≤ 10 mg/kg Co ≤ 10 ... Fe ≤ 10 mg/kg K ≤ 500 mg/kg Mg ... 5000 mg/kg Ni ≤ 10 mg/kg Pb ≤ 10 ...
Medicine Products: